Ginkgo Bioworks Holdings (DNA) Other Non Operating Income (2021 - 2026)

Ginkgo Bioworks Holdings' Other Non Operating Income history runs 6 years deep, the most recent figure standing at -$4.8 million for Q1 2026.

• Quarterly Other Non Operating Income fell 111.78% year-over-year to -$4.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193000.0 (down 91.27% YoY) and the FY2024 annual result came in at -$1.5 million, up 94.77% from the prior year.
• Other Non Operating Income was -$4.8 million for Q1 2026 at Ginkgo Bioworks Holdings, down from $5.0 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $15.9 million in Q1 2022 and bottomed at -$33.8 million in Q4 2023.
• A 5-year average of -$2.4 million and a median of $1.7 million in 2024 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2022 — Other Non Operating Income soared 189.22% — and 2025, when it tumbled 118.56%.
• Ginkgo Bioworks Holdings' Other Non Operating Income stood at -$31.9 million in 2022, then dropped by 5.91% to -$33.8 million in 2023, then surged by 95.58% to -$1.5 million in 2024, then soared by 432.31% to $5.0 million in 2025, then slumped by 196.11% to -$4.8 million in 2026.
• Business Quant data shows DNA's Other Non Operating Income at -$4.8 million in Q1 2026, $5.0 million in Q2 2025, and -$2.2 million in Q1 2025.